{"id":3727,"date":"2024-05-11T19:21:33","date_gmt":"2024-05-11T17:21:33","guid":{"rendered":"https:\/\/rand-biotech.com\/de\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\/company-profile-fra\/"},"modified":"2024-05-21T22:07:09","modified_gmt":"2024-05-21T20:07:09","slug":"company-profile-de","status":"publish","type":"page","link":"https:\/\/rand-biotech.com\/de\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\/company-profile-de\/","title":{"rendered":"Company Profile – About – DE"},"content":{"rendered":"

[vc_row][vc_column width=”1\/1″][vc_custom_heading heading_semantic=”h1″ text_size=”h1″ text_weight=”300″]FIRMENPROFIL[\/vc_custom_heading][vc_separator sep_color=”color-wvjs” el_width=”200px” el_height=”2px”][vc_column_text]Unser Firmensitz befindet sich im international gut bekannten biomedizinischen Bezirk Mirandola, RanD ist eine auf \u201cKnow-how\u201d basierende Firma, gegr\u00fcndet in 1999 mit \u00fcber 30-j\u00e4hriger Erfahrung im biomedizinischen Sektor.<\/p>\n

Der Name RanD hat seinen Ursprung in der phonetischen englischen \u00dcbersetzung R&D (Forschung und Entwicklung) als direkter Ausdruck der RanD Aktivit\u00e4ten, die Entwicklung technisch innovativer Technologien, die au\u00dferhalb des K\u00f6rpers liegen<\/strong> und dies bei gleichzeitig extrem einfacher Handhabung.<\/p>\n

Im Laufe der Jahre entwickelte RanD eine ganze Reihe von Produkten, die sich haupts\u00e4chlich auf chirurgische Onkologie<\/strong> fokussierte. Ebenso erweitert RanD sein eigenes Knowhow in Bezug auf die Entwicklung und Weiterentwicklung von tangierenden Produkten in Bereichen der Unterst\u00fctzung von Leberpatienten, Herzpatienten und der Dialyse<\/strong>.<\/p>\n

RanD arbeitet in allen Herstellungsprozessen bez\u00fcglich Ger\u00e4te und Zubeh\u00f6r<\/strong>, dies sichert h\u00f6chste Qualit\u00e4tsstandards in jeder Herstellungsphase.<\/p>\n

RanD Produkte werden gegenw\u00e4rtig weltweit direkt vertrieben oder mittels st\u00e4ndig expandierendem Vertriebsnetzwerk verkauft, regelm\u00e4\u00dfig \u00fcberwacht von RanD. Dank diesem gut aufgestellten Netzwerk kann der Kunde sich auf einen hochprofessionellen \u201cAfter-Sales-Service\u201d verlassen.<\/p>\n

\u00dcber die Jahre hat RanD eine enge Zusammenarbeit mit international renommierten Zentren aufgebaut, die einen wichtigen Beitrag zur Entwicklung von Systemen leisten, um den Anforderungen der Patienten zu gen\u00fcgen.<\/p>\n

Vor diesem Hintergrund ist RanD in aktiver Zusammenarbeit mit den Organisationskomitees von Kongressen und wissenschaftlich internationalen Veranstaltungen. Dies beinhaltet ebenfalls st\u00e4ndige Trainingsaktivit\u00e4ten, f\u00fcr \u00c4rzte, Perfusionisten und OP Pflegeteam<\/p>\n

 <\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″][vc_custom_heading text_size=”h1″ text_weight=”300″ text_color=”color-163594″]Unsere mission[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row row_height_percent=”0″ overlay_alpha=”50″ equal_height=”yes” gutter_size=”3″ shift_y=”0″][vc_column column_width_percent=”100″ align_horizontal=”align_center” back_color=”color-692600″ overlay_alpha=”50″ gutter_size=”3″ medium_width=”0″ shift_x=”0″ shift_y=”0″ z_index=”0″ css_animation=”bottom-t-top” animation_delay=”400″ width=”1\/1″][vc_custom_heading text_weight=”400″ text_color=”color-xsdn”]Wir m\u00f6chten Patienten mit hochentwickelten technischen Produkten helfen, ihre Gesundheit bedeutend zu verbessern.[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″][vc_custom_heading text_size=”h1″ text_weight=”300″ text_color=”color-163594″][\/vc_custom_heading][vc_custom_heading heading_semantic=”h1″ text_size=”h1″ text_weight=”300″ text_color=”color-163594″]Meilensteine[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row row_height_percent=”0″ overlay_alpha=”50″ equal_height=”yes” gutter_size=”3″ shift_y=”0″][vc_column column_width_percent=”100″ back_color=”color-gyho” overlay_alpha=”50″ gutter_size=”3″ medium_width=”0″ shift_x=”0″ shift_y=”0″ z_index=”0″ css_animation=”bottom-t-top” width=”1\/3″][vc_single_image media=”1193″ media_width_percent=”100″][vc_custom_heading text_weight=”400″]1999[\/vc_custom_heading][vc_custom_heading heading_semantic=”h5″ text_size=”h5″ text_weight=”400″ text_color=”color-jevc”]RanD Niederlassung<\/strong>[\/vc_custom_heading][\/vc_column][vc_column column_width_percent=”100″ back_color=”color-692600″ overlay_alpha=”50″ gutter_size=”3″ medium_width=”0″ shift_x=”0″ shift_y=”0″ z_index=”0″ css_animation=”bottom-t-top” animation_delay=”400″ width=”1\/3″][vc_single_image media=”932″ media_width_percent=”100″ alignment=”center”][vc_custom_heading text_weight=”400″ text_color=”color-xsdn”]2001[\/vc_custom_heading][vc_custom_heading heading_semantic=”h5″ text_size=”h5″ text_weight=”400″ text_color=”color-xsdn”]Performer LRT<\/strong><\/span>
\nDas erste multifunktionale System f\u00fcr extrakorporale Kreislauftherapien: CRRT, Plasmaaustausch, k\u00fcnstliche und bio-k\u00fcnstliche Leberunterst\u00fctzung, Chirurgische Onkologie.<\/span>[\/vc_custom_heading][\/vc_column][vc_column column_width_percent=”100″ back_color=”color-gyho” overlay_alpha=”50″ gutter_size=”3″ medium_width=”0″ shift_x=”0″ shift_y=”0″ z_index=”0″ css_animation=”bottom-t-top” animation_delay=”600″ width=”1\/3″][vc_single_image media=”1191″ media_width_percent=”100″ alignment=”center”][vc_custom_heading text_weight=”400″]2005[\/vc_custom_heading][vc_custom_heading heading_semantic=”h5″ text_size=”h5″ text_weight=”400″]Performer CPB<\/strong>
\nDie erste Hoch Herz-Lungen-Maschine.<\/p>\n

Entwickelt f\u00fcr Medtronic Inc.[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row row_height_percent=”0″ overlay_alpha=”50″ equal_height=”yes” gutter_size=”3″ shift_y=”0″][vc_column column_width_percent=”100″ back_color=”color-692600″ overlay_alpha=”50″ gutter_size=”3″ medium_width=”0″ shift_x=”0″ shift_y=”0″ z_index=”0″ css_animation=”bottom-t-top” animation_delay=”800″ width=”1\/3″][vc_single_image media=”430″ media_width_percent=”100″ alignment=”center”][vc_custom_heading text_weight=”400″ text_color=”color-xsdn”]2008[\/vc_custom_heading][vc_custom_heading heading_semantic=”h5″ text_size=”h5″ text_weight=”400″ text_color=”color-xsdn”]Performer HT<\/strong>
\nDas modernste System f\u00fcr hyperthermische Perfusion im Bereich der chirurgischen Onkologie.[\/vc_custom_heading][\/vc_column][vc_column column_width_percent=”100″ back_color=”color-gyho” overlay_alpha=”50″ gutter_size=”3″ medium_width=”0″ shift_x=”0″ shift_y=”0″ z_index=”0″ css_animation=”bottom-t-top” animation_delay=”1000″ width=”1\/3″][vc_single_image media=”1197″ media_width_percent=”100″ alignment=”center”][vc_custom_heading text_weight=”400″]2012[\/vc_custom_heading][vc_custom_heading heading_semantic=”h5″ text_size=”h5″ text_weight=”400″]RanD USA
\n<\/strong>FDA-Clearance vom Performer HT & Einrichtung von RanD USA in Miami (FL)[\/vc_custom_heading][\/vc_column][vc_column column_width_percent=”100″ back_color=”color-692600″ overlay_alpha=”50″ gutter_size=”3″ medium_width=”0″ shift_x=”0″ shift_y=”0″ z_index=”0″ css_animation=”bottom-t-top” animation_delay=”1200″ width=”1\/3″][vc_single_image media=”1200″ media_width_percent=”100″ alignment=”center”][vc_custom_heading text_weight=”400″ text_color=”color-xsdn”]2016[\/vc_custom_heading][vc_custom_heading heading_semantic=”h5″ text_size=”h5″ text_weight=”400″ text_color=”color-xsdn”]Rigenerand<\/strong><\/span>
\nSpin-off-Unternehmen auf dem Gebiet der regenerativen Medizin<\/span>[\/vc_custom_heading][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column width=”1\/1″][vc_custom_heading heading_semantic=”h1″ text_size=”h1″ text_weight=”300″]FIRMENPROFIL[\/vc_custom_heading][vc_separator sep_color=”color-wvjs” el_width=”200px” el_height=”2px”][vc_column_text]Unser Firmensitz befindet sich im international gut bekannten biomedizinischen Bezirk Mirandola, RanD ist […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1721,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3727","page","type-page","status-publish","hentry"],"yoast_head":"\nTecnologie di circolazione extracorporea dedicati alla chirurgia oncologica<\/title>\n<meta name=\"description\" content=\"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rand-biotech.com\/de\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\/company-profile-de\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tecnologie di circolazione extracorporea dedicati alla chirurgia oncologica\" \/>\n<meta property=\"og:description\" content=\"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rand-biotech.com\/de\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\/company-profile-de\/\" \/>\n<meta property=\"og:site_name\" content=\"RAND\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-21T20:07:09+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/rand-biotech.com\\\/de\\\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\\\/company-profile-de\\\/\",\"url\":\"https:\\\/\\\/rand-biotech.com\\\/de\\\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\\\/company-profile-de\\\/\",\"name\":\"Tecnologie di circolazione extracorporea dedicati alla chirurgia oncologica\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rand-biotech.com\\\/#website\"},\"datePublished\":\"2024-05-11T17:21:33+00:00\",\"dateModified\":\"2024-05-21T20:07:09+00:00\",\"description\":\"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/rand-biotech.com\\\/de\\\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\\\/company-profile-de\\\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/rand-biotech.com\\\/de\\\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\\\/company-profile-de\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/rand-biotech.com\\\/de\\\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\\\/company-profile-de\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/rand-biotech.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HOME – DE\",\"item\":\"https:\\\/\\\/rand-biotech.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Company Profile – About – DE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/rand-biotech.com\\\/#website\",\"url\":\"https:\\\/\\\/rand-biotech.com\\\/\",\"name\":\"RAND\",\"description\":\"Your Partner in Surgical Oncology\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/rand-biotech.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tecnologie di circolazione extracorporea dedicati alla chirurgia oncologica","description":"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rand-biotech.com\/de\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\/company-profile-de\/","og_locale":"de_DE","og_type":"article","og_title":"Tecnologie di circolazione extracorporea dedicati alla chirurgia oncologica","og_description":"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica","og_url":"https:\/\/rand-biotech.com\/de\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\/company-profile-de\/","og_site_name":"RAND","article_modified_time":"2024-05-21T20:07:09+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rand-biotech.com\/de\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\/company-profile-de\/","url":"https:\/\/rand-biotech.com\/de\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\/company-profile-de\/","name":"Tecnologie di circolazione extracorporea dedicati alla chirurgia oncologica","isPartOf":{"@id":"https:\/\/rand-biotech.com\/#website"},"datePublished":"2024-05-11T17:21:33+00:00","dateModified":"2024-05-21T20:07:09+00:00","description":"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica","breadcrumb":{"@id":"https:\/\/rand-biotech.com\/de\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\/company-profile-de\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rand-biotech.com\/de\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\/company-profile-de\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/rand-biotech.com\/de\/rand-hipec-hithoc-hyperthermische-perfusion-isolierten-organ\/company-profile-de\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rand-biotech.com\/de\/"},{"@type":"ListItem","position":2,"name":"HOME – DE","item":"https:\/\/rand-biotech.com\/de\/"},{"@type":"ListItem","position":3,"name":"Company Profile – About – DE"}]},{"@type":"WebSite","@id":"https:\/\/rand-biotech.com\/#website","url":"https:\/\/rand-biotech.com\/","name":"RAND","description":"Your Partner in Surgical Oncology","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rand-biotech.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"}]}},"_links":{"self":[{"href":"https:\/\/rand-biotech.com\/de\/wp-json\/wp\/v2\/pages\/3727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rand-biotech.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/rand-biotech.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/rand-biotech.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/rand-biotech.com\/de\/wp-json\/wp\/v2\/comments?post=3727"}],"version-history":[{"count":6,"href":"https:\/\/rand-biotech.com\/de\/wp-json\/wp\/v2\/pages\/3727\/revisions"}],"predecessor-version":[{"id":3739,"href":"https:\/\/rand-biotech.com\/de\/wp-json\/wp\/v2\/pages\/3727\/revisions\/3739"}],"up":[{"embeddable":true,"href":"https:\/\/rand-biotech.com\/de\/wp-json\/wp\/v2\/pages\/1721"}],"wp:attachment":[{"href":"https:\/\/rand-biotech.com\/de\/wp-json\/wp\/v2\/media?parent=3727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}